Expert Speakers

2023 Speakers

Explore the line up of 100+ fresh new speakers and returning key opinion leaders, presenting at the
3rd mRNA-Based Therapeutics Summit.

PHARMA & INDUSTRY LEADERS

ACADEMIC LEADERS

LEADING SOLUTION PARTNERS

PHARMA, BIOTECH & INDUSTRY LEADERS

Basim Hilal

Vice President - Global Regulatory Affairs CMC

BioNTech US

Michiel Lodder

Chief Executive Officer

20Med Therapeutics

Walter Schmidt

Director – mRNA Division

ADvantage Therapeutics

Petro Terblanche

Managing Director

Afrigen Biologics

Amin Khan

Chief Science Advisor

Afrigen Biologics

Daryl Drummond

CSO & Co-Founder

Akagera Medicines

Annette Bak

Head of Advanced Drug Delivery

AstraZeneca

Manmohan Singh

Chief Technology Officer

Beam Therapeutics

Mohamed ElSayed

Executive Vice President & Chief Technology Officer

RVAC Medicines

Guilhem Richard

CTO

EpiVax Therapeutics

Andreas Kuhn

SVP – RNA Biochemistry & Manufacturing

BioNTech SE

Pawel Widomski

Senior Director - Global Regulatory Affairs CMC

BioNTech SE

Michael Wenger

Vice President - Clinical Development

BioNTech SE

June Kim

CMC Lead

CEPI

Arun Kumar

Preclinical Vaccines Development Lead

CEPI

Linda Marban

CEO

Capricor Therapeutics

Li Li

Principal Scientist

Merck & Co

Sonia Golombek

Senior R&D Manager

Elastrin Therapeutics

PD Dr. Carsten Rudolph

CEO

Ethris GmbH

Marco Cavaleri

Head of Anti-infectives & Vaccines

European Medicines Agency

Gregory Fiore

Chief Executive Officer

Exacis Biotherapeutics

Lusheng Fan

Investigator

GeneLeap Biotech

Elaine Peters

Director – Analytical – Individualized Cell & Gene Therapies

Genentech

Matthew Hawryluk

Executive VP & CBO

Gritstone Bio

YUSUF ERKUL

CEO

Kernal Biologics Inc.

Manfred Kraus

VP – R&D

Kernal Bio

Francis Poulin

Vice President - Ribonucleic Acid Science & Platform Analytics

Laronde

Patrick Finn

VP – Rare Disease Research & Preclinical Development

Moderna

Sonia Stoszek

Executive Director & Program Lead – RSV Vaccines

Moderna

Anne Aunins

Executive Director & Program Lead - COVID-19 Vaccines

Moderna

Antonella Lozito

Executive Director, Infectious Disease, Global Regulatory Strategy

Moderna

Curtis Dobrowolski

Co-Founder

Nava Therapeutics

Bill Grier

Associate Director – Drug Substance Process Development

Omega Therapeutics

Gilles besin

Chief Scientific Officer

Orbital Therapeutics

Daniel Tondera

Head of Biology

Pantherna Therapeutics

John Androsavich

Head of Global Ribonucleic acid Emerging Science Lead

Pfizer

Helen McCarthy

CEO

Phion Therapeutics Limited

Aleksandra Pastrak

CMO

Providence Therapeutics

Jason Zhang

Chief Scientific Officer & Co-Founder

RVAC

Roberto Guerciolini

CMO

RVAC Medicines

Vira Bitko

VP & Head of Vaccines

RVAC Medicines

Arunan Kaliyaperumal

VP – Preclinical Biology

ReCode Therapeutics

Daniella Ishimaru

Principal Scientist,

ReCode Therapeutics

Kathir Muthusamy

Associate Director

Regeneron Pharmaceuticals

Yue Fu

Staff Scientist

Regeneron Pharmaceuticals Inc

John Ramunas

CEO

Rejuvenation Technologies

Nathaniel Wang

CEO & Co-Founder

Replicate Bioscience

Kathleen Francissen

Global Head of Regulatory PT Cell & Gene Therapies

Roche

Dan Shores

Partner

Rothwell Figg

Frank DeRosa

Chief Technology Officer & Global Head of Research, mRNA Center of Excellence

Sanofi

Gregory Troiano

Head of cGMP Strategic Supply & Operations - mRNA Center of Excellence

Sanofi

Joshua DiNapoli

Global Project Head - mRNA Platform Development

Sanofi Pasteur

Jianmei Kochling

Senior Director – Analytical Development - mRNA Center of Excellence

Sanofi

Vikram Agarwal

Head of mRNA Platform Design Data Science - mRNA Center of Excellence

Sanofi

Pierre Cote

Head of Strategic Partnership and Innovation Management

Sanofi

Nicholas Manzo

Director – CMC RNA Vaccines

Seqirus

Mohammad Safari

Head of Analytical Biochemistry

Seqirus Inc.

Dahyana Arias Escayola

Senior Scientist of Ribonucleic Acid Discovery Biology

Strand Therapeutics Inc.

Apiwat Wangweerawong

Associate Director - Lipid Nanoparticle Chemistry

Tessera Therapeutics

Jasdave Chahal

Co-Founder and Chief Scientist

Tiba Biotech LLC

Tamar Grossman

Vice President & Head Of Ribonucleic Acid, Global Gene Therapy & Delivery

The Janssen Pharmaceutical

Mustafa Turkoz

Head of Immunology

Turn Biotechnologies

Jan Komrska

Contracts Manager – Supply Division

UNICEF

Peter Marks

Director - Center For Biologics Evaluation & Research

US Food & Drug Administration (FDA)

Mike Zimmer

Director - Rare Diseases; Rare Research & Preclinical Development

Moderna

Aditi Mehta

Associate Director; Head of mRNA Process & Delivery

MilliporeSigma

Diane McCarthy

Senior Director, Science and Standards, Global Biologics

U.S. Pharmacopeia

Tao Niu

Associate Director – Clinical & Quantitative Pharmacology

Vertex Pharmaceuticals

Joshua Bell

Senior Director - Enterprise Strategy

Tempus

Cory Smith

Senior Product Manager - Nucleic Acid Services

TriLink BioTechnologies

Romain Micol

President, Co-Founder & CEO

Combined Therapeutics

ACADEMIC LEADERS

Philip John Santangelo

Assistant Professor

Emory University School of Medicine

Toni Celià-Terrassa

Principal Investigator

Hospital del Mar Medical Research Institute (IMIM)

Prashant Yadav

Professor & Senior Fellow

INSEAD & Centre for Global Development

Hirohide Saito

Professor

Kyoto University

Xiaoyuan (Shawn) Chen

Professor

National University of Singapore

Gal Cafri

Immunotherapy & Genetic Engineering Group Leader

Sheba Medical Center

Becki Yi Kuang

Assistant Professor,

The Hong Kong University of Science & Technology

Anna Blakney

Assistant Professor

University of British Columbia

Simone Spuler

Professor; Co-founder

Max Delbrück Center for Molecular Medicine & Charité – Universitätsmedizin Berlin; MyoPax

Chantal Pichon

Professor

University of Orleans

BOWEN LI

Assistant Professor & Chair Of Ribonucleic Acid Vaccines & Therapeutics Research

University of Toronto

Heinrich Haas

Vice President - RNA Formulation & Drug Delivery

Johannes Gutenberg-Universität Mainz

LEADING SOLUTION PARTNERS

Venkata Indurthi

CSO

Aldevron

Diana Marcantonio

Director - Biology

Applied BioMath

May Guo

Vice President - Nucleic Acids

ReciBioPharm

Ioana Panait

Research Analyst

Beacon Intelligence

Scott Alderucci

Director - mRNA Process Development & GMP

Curia Global

David Sokolowski

Nucleic Acid Therapeutics & Global Workflow Manager

Cytiva

Marco Blanchette

VP - R&D

Eclipse Bioinnovations

Jiancun (Larry) Zhang

CEO

Henovcom

Senthil Ramaswamy

Executive Director - R&D, CGT

Lonza

Sudhakar Voruganti

Business Development Director

Pfanstiehl

Aaron Larsen

Senior Director & Technical Head - Nucleic Acid Franchise

Resilience Inc

Pierre Catignol

EVP & Head of Manufacturing

Samsung Biologics

Aleš Štrancar

Executive Managing Director

Sartorius BIA Separations

Jason Coleman

Clinical Application Scientist Lead

Precision NanoSystems

Matthew Stone

Advanced Workflow Specialist

Sciex

Darwin Asa

Market Development Manager

Thermo Fisher Scientific Inc.